Ligand validation:5DYT

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5DYT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5DYT_NAG_B_608	24%	71%	0.28	0.909	0.5	0.62	-	1	1	0	100%	0.9333
5DYT_NAG_A_610	22%	58%	0.214	0.833	0.53	1.05	-	1	0	1	100%	0.9333
5DYT_NAG_B_607	21%	68%	0.175	0.783	0.43	0.78	-	1	0	0	100%	0.9333
5DYT_NAG_B_611	12%	60%	0.284	0.81	0.51	1.02	-	1	0	1	100%	0.9333
5DYT_NAG_B_603	8%	52%	0.354	0.825	0.41	1.43	-	3	0	0	100%	0.9333
5DYT_NAG_B_602	6%	78%	0.238	0.667	0.45	0.44	-	-	0	0	100%	0.9333
5DYT_NAG_A_601	6%	71%	0.312	0.737	0.64	0.47	-	-	0	0	100%	0.9333
5DYT_NAG_B_601	3%	47%	0.304	0.653	0.93	1.1	1	1	0	0	100%	0.9333
5LKR_NAG_B_608	57%	68%	0.094	0.869	0.56	0.67	-	1	0	0	100%	0.9333
5DYW_NAG_A_625	55%	54%	0.134	0.9	0.64	1.11	1	1	0	1	100%	0.9333
6F7Q_NAG_B_611	51%	56%	0.137	0.89	0.82	0.89	1	1	0	0	100%	0.896
7Q1P_NAG_A_603	49%	45%	0.122	0.867	1.1	1.03	1	1	0	0	100%	0.9333
1P0I_NAG_A_538	48%	58%	0.135	0.877	0.77	0.83	-	-	0	0	100%	0.6667
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.